服务范畴
- 哮喘 / 气管敏感
- 慢性阻塞性肺疾病 (COPD)
- 感染性肺炎
- 肺结节/肺部阴影
- 肺结核
- 纵隔疾病
- 肺癌
- 睡眠窒息症
- 间质性肺疾病
- 胸膜疾病 (胸腔积液 / 气胸)
- 治疗性支气管镜检查
- 诊断性支气管镜检查
- 唿吸衰竭
出版物
- Kwok, W. C., Chau, C. H., Tam, T. C. C., Lam, F. M., & Ho, J. C. M. (2023). Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease, 18, 1145–1153.
- Kwok, W. C., Tam, T. C. C., Lam, D. C. L., Ip, M. S. M., & Ho, J. C. M. (2023). Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis. The clinical respiratory journal, 17(6), 548–555.
- Kwok, W. C., Tam, T. C. C., Sing, C. W., Chan, E. W. Y., & Cheung, C. L. (2023). Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong. Pharmacoepidemiology and drug safety, 1-6.
- Kwok, W. C., Ma, T. F., Ho, J. C. M., Lam, D. C. L., Sit, K. Y., Ip, M. S. M., Au, T. W. K., & Tam, T. C. C. (2023). Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma. Respirology (Carlton, Vic.), 28(7), 669–676
- Kwok, W. C., Tam, T. C. C., Sing, C. W., Chan, E. W. Y., & Cheung, C. L. (2023). Validation of Diagnostic Coding for Asthma in an Electronic Health Record System in Hong Kong. Journal of asthma and allergy, 16, 315–321.
- Kwok, W. C., Tsoi, M. F., Leung, S. H. I., Tsui, C. K., Tam, T. C. C., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Ho, P. L. (2023). Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting. Viruses, 15(3), 610.
- Kwok, W. C., Tam, T. C. C., Lam, D. C. L., Leung, J. K. C., Chan, K. P. F., Chan, S. K. S., Chiang, K. Y., Ip, M. S. M., & Ho, J. C. M. (2023). Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respiratory research, 24(1), 53.
- Kwok, W. C., Leung, S. H. I., Tam, T. C. C., Ho, J. C. M., Lam, D. C., Ip, M. S. M., & Ho, P. L. (2023). Efficacy of mRNA and Inactivated Whole Virus Vaccines Against COVID-19 in Patients with Chronic Respiratory Diseases. International journal of chronic obstructive pulmonary disease, 18, 47–56.
- Zouari, F., Oon, W. Y., Modak, D., Lee, W. H., Kwok, W. C., Cao, P., Lee, W. N., Tam, T. C. C., Wong, E. C., & Chan, R. W. (2022). Affordable, portable and self-administrable electrical impedance tomography enables global and regional lung function assessment. Scientific reports, 12(1), 20613.
- Zouari, F., Oon, W. Y., Modak, D., Kwok, W. C., Cao, P., Lee, W. N., Tam, T. C. C., Wong, E. C., & Chan, R. W. (2022). Standalone electrical impedance tomography predicts spirometry indicators and enables regional lung assessment. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2022, 3277–3280.
- Duan, J., Tan, F., Bi, N., Chen, C., Chen, K. N., Cheng, Y., Chu, Q., Ge, D., Hu, J., Huang, Y., Jiang, T., Long, H., Lu, Y., Shi, M., Wang, J., Wang, Q., Yang, F., Yang, N., Yao, Y., Ying, J., … Gao, S. (2022). Expert consensus on perioperative treatment for non-small cell lung cancer. Translational lung cancer research, 11(7), 1247–1267.
- Kwok, W. C., Lam, D. C. L., Ip, M. S. M., Tam, T. C. C., & Ho, J. C. M. (2022). Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities. Anti-cancer drugs, 33(10), 1139–1144.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Ip, M. S. M., & Lam, D. C. L. (2022). Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use. Journal of thoracic disease, 14(6), 1880–1889.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Ip, M. S. M., & Lam, D. C. L. (2022). Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first-line setting. Thoracic cancer, 13(14), 2057–2063.
- Kwok, W. C., Cheong, T. F., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Tam, T. C. C. (2023). Clinical efficacy and safety of pemetrexed with or without either Bevacizumab or Pembrolizumab in patients with metastatic nonsquamous non-small cell carcinoma. Asia-Pacific journal of clinical oncology, 19(1), 87–95.
- Wang, A., Tam, T. C. C., Poon, H. M., Yu, K.-C., and Lee, W.-N., “NaviAirway: a Bronchiole-sensitive Deep Learning-based Airway Segmentation Pipeline”, <i>arXiv e-prints</i>, 2022.
- Kwok, W. C., Tam, A. R., Ho, J. C. M., Lam, D. C. L., Tam, T. C. C., Chan, K. P. F., Wang, J. K. L., Ip, M. S. M., & Hung, I. F. N. (2022). Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19). The clinical respiratory journal, 16(4), 293–300.
- Chi-Chun Tam, T., & Chung-Man Ho, J. (2021). Navigational bronchoscopy: we should choose to do it not because it´s easy, but because it´s hard. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 25(1), 1–2.
- Kwok, W. C., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Tam, T. C. C. (2021). Risk factors of nephrotoxicity of maintenance pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung. Lung cancer (Amsterdam, Netherlands), 162, 169–174.
- Kwok, W. C., Wong, C. K., Ma, T. F., Ho, K. W., Fan, L. W., Chan, K. F., Chan, S. S., Tam, T. C., & Ho, P. L. (2021). Modelling the impact of travel restrictions on COVID-19 cases in Hong Kong in early 2020. BMC public health, 21(1), 1878.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Ip, M. S. M., & Lam, D. C. L. (2021). Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications. Respiratory research, 22(1), 132.
- Chan, K. F., Kwok, W. C., Ma, T. F., Hui, C. H., Tam, T. C., Wang, J. K., Ho, J. C., Lam, D. C., Sau-Man Ip, M., & Ho, P. L. (2021). Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 Pandemic. Annals of the American Thoracic Society, 18(10), 1624–1633.
- Kwok, W. C., Cheong, T. F., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Tam, T. C. C. (2021). Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid. Lung cancer (Amsterdam, Netherlands), 152, 15–20.
- Zeng, Z., Yan, B., Chen, Y., Zhang, L., Zhu, J., Yang, F., Wei, F., Tam, T. C. C., Kauffmann-Guerrero, D., Soo, R. A., Ren, X., & You, J. (2020). Survival benefit and toxicity profile of adjuvant icotinib for patients with EGFR mutation-positive non-small cell lung carcinoma: a retrospective study. Translational lung cancer research, 9(6), 2401–2410.
- Kwok, C. W., Ho, J. C. M., Lam, D. C. L. , Sze M. L. M., Ip, M. S. M.and Tam, T. C. C. *, Clinical Impact of Gastric Acid Suppressants Use on the Efficacy of Gefitinib in Patients with Advanced Adenocarcinoma of the Lung Harboring Common EGFR Mutations, Clinical Cancer Drugs 2020; 7: 57
- Kwok, W. C., Lam, D. C. L., Chiang, K. Y., Ho, J. C. M., Ip, M. S. M., & Tam, T. C. C. (2020). Real world experience on maintenance chemotherapy with gemcitabine in second line setting for advanced non-small cell lung carcinoma. Journal of chemotherapy (Florence, Italy), 32(8), 429–436.
- Tam T. (2020). Adjuvant EGFR-TKIs-based therapy: are we ready?. Translational lung cancer research, 9(4), 948–950.
- Chan, K. P. F., Ma, T. F., Kwok, W. C., Leung, J. K. C., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Tam, T. C. C., Ip, M. S. M., & Ho, P. L. (2020). Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respiratory medicine, 171, 106085.
- Chiang, K. Y., Ho, J. C., Chong, P., Tam, T. C., Lam, D. C., Ip, M. S., Lee, Y. G., & Lui, M. M. (2020). Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer. Respirology (Carlton, Vic.), 25(11), 1167–1173.
- Kwok, W. C., Ho, J. C. M., Lam, D. C. L., Lui, M. M. S., Ip, M. S. M., & Tam, T. C. C. (2021). When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival. Asia-Pacific journal of clinical oncology, 17(2), e35–e39.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Lui, M. M. S., Ip, M. S. M., & Lam, D. C. L. (2019). Efficacy of gefitinib at reduced dose in EGFR mutant non-small cell lung carcinoma. Anti-cancer drugs, 30(10), 1048–1051.
- Kwok, W. C., Cheng, K. C., Lam, D. C. L., & Tam, T. C. C. (2019). First successful case of chemical pleurodesis with oxytetracycline through Rocket® Pleural Vent™: ambulatory pneumothorax device for pneumothorax. Respirology case reports, 7(7), e00471.
- Kwok, W. C., Liang, B. M., Lui, M. M. S., Tam, T. C. C., Sim, J. P. Y., Tse, E. W. C., Leung, A. Y. H., Kwong, Y. L., Lie, A. K. W., Ip, M. S. M., & Lam, D. C. L. (2019). Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome. Respirology (Carlton, Vic.), 24(5), 459–466.
- Kwok, W. C., Tam, T. C. C., & Lam, D. C. L. (2018). First reported case of afatinib-associated toxic megacolon. Respirology case reports, 6(7), e00360.
- Kwok, W. C., Tam, T. C. C., Chi Leung Lam, D., Ip, M. S. M., & Lui, M. M. S. (2018). Pulmonary embolism developing after therapeutic drainage of malignant pleural effusions. Respiratory medicine case reports, 25, 122–123.
- Terence Tam. Use of the New Veran Always-On Tip Tracked Sensor with Olympus GuideSheath System to Arrive at a Small Peripheral Ground-Glass Nodule. CHEST Volume 152, Issue 4, Supplement, Pages A641–A642
- Kwok, W. C., Tam, T. C., Lui, M. M., Lam, D. C., & Ho, J. C. (2017). Control of brain metastases with alectinib in anaplastic lymphoma kinase-rearranged lung cancer. Respirology case reports, 5(3), e00224.
- Lam, J. C. M., Lai, A. Y. K., Tam, T. C. C., Yuen, M. M. A., Lam, K. S. L., & Ip, M. S. M. (2017). CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure. Sleep & breathing = Schlaf & Atmung, 21(2), 377–386.
- Wong, W. M., Tam, T. C., Wong, M. K., Lui, M. M., Ip, M. S., & Lam, D. C. (2016). Managing malignant pleural effusion with an indwelling pleural catheter: factors associated with spontaneous pleurodesis. Hong Kong medical journal = Xianggang yi xue za zhi, 22(4), 334–340.
- Lam, D. C., Tam, T. C., Lau, K. M., Wong, W. M., Hui, C. K., Lam, J. C., Wang, J. K., Lui, M. M., Ho, J. C., & Ip, M. S. (2015). Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer. Clinical lung cancer, 16(6), 507–513.
- Ho, J. C., Tam, T. C., & Lam, S. K. (2013). Salvage therapy beyond targeted therapy in lung adenocarcinoma. Seminars in respiratory and critical care medicine, 34(6), 837–844.
- Ho, Tam, Lam, 2013. Personalized Treatment of Lung Adenocarcinoma, Clinical Pulmonary Medicine, 20(6), 309-314.
- Tam, T. C., Ho, J. C., Wong, M. K., Wong, W. M., Wang, J. K., Lam, J. C., Lui, M. M., Lam, W. K., Ip, M. S., & Lam, D. C. (2013). Treatment outcomes in elderly with advanced-stage non-small cell lung cancer. Lung, 191(6), 645–654.
- Wong, M. K., Ho, J. C., Loong, F., Lam, D. C., Wong, W. M., Tam, T. C., Han, L., & Ip, M. S. (2013). Endobronchial ultrasound-guided transbronchial needle aspiration in lung cancer: the first experience in Hong Kong. Hong Kong medical journal = Xianggang yi xue za zhi, 19(1), 20–26.
- Wong, M. K., Tam, T. C., Lam, D. C., Ip, M. S., & Ho, J. C. (2012). EBUS-TBNA in patients presented with superior vena cava syndrome. Lung cancer (Amsterdam, Netherlands), 77(2), 277–280.
- Tam, T. C., Chan, K. Y., Ho, S. L., Luk, J. K., & Chu, L. W. (2005). Herpetic shoulder paresis in a Chinese elderly patient. Hong Kong medical journal = Xianggang yi xue za zhi, 11(5), 399–402.
相关服务
先进诊断性支气管镜检查
呼吸系统科
先进诊断性支气管镜诊断是一种能够对肺部疾病进行诊断和分期的微创检查。服务包括支气管内超声检查 (EBUS)、虚拟支气管导航 (VBN)、电磁导航支气管镜检查 (ENB)、动态扫描引导支气管镜检查等。
显示详情
哮喘
呼吸系统科
一种慢性唿吸系统疾病,表现为气喘、唿吸困难、胸闷等,需长期治疗和控制。
显示详情
间质性肺病
呼吸系统科心胸肺外科
间质性肺病是一组影响肺间质(肺泡壁及其周围组织)的疾病,主要特徵是肺部组织炎症和纤维化,导致气体交换障碍。
显示详情
肺癌
临床肿瘤科外科呼吸系统科心胸肺外科
肺癌是一种恶性肿瘤,需及早发现和治疗,以达致最佳治疗效果。多学科讨论/协作是现代肺癌诊疗的大趋势。
显示详情
肺结节
呼吸系统科心胸肺外科
肺结节可能是由炎症或良性增生等非癌症疾病引起,但也可能是癌症的早期表徵。
显示详情
纵隔肿物
呼吸系统科心胸肺外科
纵隔肿物的可能病因包括淋巴结肿胀(由感染、发炎、自体免疫性疾病或恶性肿瘤等引起)、肿瘤(如胸腺瘤,生殖细胞瘤,神经鞘膜瘤等)、囊肿、或其他疾病。
显示详情
胸腔积液 (肺积水)
呼吸系统科心胸肺外科
胸腔积液 (俗称肺积水),指胸膜腔内液体异常积聚。正常情况下胸膜腔内仅有少量液体(10-20 毫升)以润滑胸膜运动,当液体量增加,可能压逼肺组织,可导致呼吸困难、胸痛及其他呼吸系统症状。
显示详情
肺炎 / 肺结核
呼吸系统科
肺炎是一种可能由细菌、病毒或其他病原体引起的肺部感染。肺结核病 (俗称肺痨) 则是一种可以通过感染者咳嗽或打喷嚏时释放的微小飞沫传播的肺部感染。肺炎/肺结核的治疗以内科为主,小部分病人可能需要外科手术协助诊断或处理与疾病相关的併发症(如胸腔积液/积脓、肺復张不良等)。
显示详情
呼吸衰竭
呼吸系统科心胸肺外科
当肺部无法充分履行为身体提供氧气和排出二氧化碳的基本功能时,就会出现呼吸衰竭。导致呼吸衰竭的原因有很多。例如细菌/病毒感染、外伤、肿瘤或者某些药物损害等。
显示详情
睡眠窒息症
耳鼻喉科呼吸系统科
睡眠窒息症是一种常见的睡眠呼吸暂停症,表现为打鼾、呼吸暂停等,需注意治疗和生活习惯改善。
显示详情
治疗性支气管镜检查
呼吸系统科
治疗性支气管镜检查是一种微创手术/程序,利用幼细而有弹性的软性支气管镜,诊断和治疗呼吸系统疾病。
显示详情
上呼吸道感染
家庭医学呼吸系统科
由病毒或细菌引起的呼吸系统疾病,常见病徵包括发烧、喉咙痛、流鼻水等,一般在三星期内会自然痊癒。
显示详情